Brian E Schultz

Years Active: 2017-2018
Publications (10 Years): 2

Gilead Sciences Inc

Harvard University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Gilead Sciences Inc

United States

Director :: Biology

Education History

Harvard University

United States

PHD :: Chemistry

University of Washington

United States

BSC :: Chemistry

Publications

Richard L Mackman, Victoria A Steadman, David K Dean, Petr Jansa, Karine G Poullennec, Todd Appleby, Carol Austin, Caroline A Blakemore, Ruby Cai, Carina Cannizzaro, Gregory Chin, Jean-Yves C Chiva, Neil A Dunbar, Hans Fliri, Adrian J Highton, Hon Hui, Mingzhe Ji, Haolun Jin, Kapil Karki, Andrew J Keats, Linos Lazarides, Yu-Jen Lee, Albert Liclican, Michael Mish, Bernard Murray, Simon B Pettit, Peter Pyun, Michael Sangi, Rex Santos, Jonathan Sanvoisin, Uli Schmitz, Adam Schrier, Dustin Siegel, David Sperandio, George Stepan, Yang Tian, Gregory M Watt, Hai Yang, Brian E Schultz
Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle. Journal of medicinal chemistry 61 (21) (2018)
Victoria A Steadman, Simon B Pettit, Karine G Poullennec, Linos Lazarides, Andrew J Keats, David K Dean, Steven J Stanway, Carol A Austin, Jonathan A Sanvoisin, Gregory M Watt, Hans G Fliri, Albert C Liclican, Debi Jin, Melanie H Wong, Stephanie A Leavitt, Yu-Jen Lee, Yang Tian, Christian R Frey, Todd C Appleby, Uli Schmitz, Petr Jansa, Richard L Mackman, Brian E Schultz
Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A. Journal of medicinal chemistry 60 (3) (2017)

Brian E Schultz.css-eqlu8i{font-size:small;padding-left:4px;}